Johnson & Johnson joined the industry trend of shedding weight in medtech last year when it announced plans to separate its orthopedics business into a standalone company. Now, reports have emerged ...

Johnson & Johnson will separate its orthopaedics business to create DePuy Synthes, enhancing strategic focus and stakeholder value. The separation aims to strengthen Johnson & Johnson's focus on ...

Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the Company’s intent to separate its Orthopaedics business to enhance the strategic and operational focus of each company and drive value ...

Johnson & Johnson’s JNJ wholly-owned orthopedics company, DePuy Synthes, recently announced the launch of TriLEAP Lower Extremity Anatomic Plating System, a comprehensive system with low-profile, ...

Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, is launching a proprietary dual-use robotics and standalone navigation platform developed in ...

Johnson & Johnson MedTech’s orthopedics division, DePuy Synthes, has claimed an FDA clearance for its Velys surgical robot that expands its use into partial knee replacements. While total knee ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Meet 2023 Women of Influence honoree Leslie Storms ...

Please provide your email address to receive an email when new articles are posted on . DePuy Synthes announced it has acquired OrthoSpin Ltd., according to a company press release. With the ...

PALM BEACH GARDENS, Fla., Nov. 22, 2021 /PRNewswire/ -- DePuy Synthes, The Orthopaedics Company of Johnson & Johnson*, has launched the UNIUM™ System as the newest addition to its Power Tools ...

SOLOTHURN, Switzerland, June 29, 2020 /PRNewswire/ -- The Johnson & Johnson Medical Devices Companies* today announced that Synthes GmbH has renewed a five-year cooperation agreement with the AO ...